| Third Point details stakes in U.S. Steel, Kenvue in filing |
Billionaire investor Daniel Loeb's hedge fund Third Point on Thursday detailed the size of its stakes in U.S. Steel and Kenvue , companies that shareholders hope will soon benefit from being bought by someone. |
reuters.com |
2025-05-16 00:12:44 |
Czytaj oryginał (ang.) |
| Everyday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier Communities |
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. today announced its global efforts in celebration of Kenvue Cares Week, the company's signature annual volunteer initiative. |
businesswire.com |
2025-05-14 10:45:00 |
Czytaj oryginał (ang.) |
| Kenvue: First Quarter A Sign Of Challenging Times, But Still A Solid Long-Term Play |
Kenvue, a solid dividend-paying stock spun off from Johnson & Johnson, offers long-term upside despite current economic challenges and declining consumer sentiment. Recent earnings showed slight revenue growth, but declines in organic sales and margins, impacted by currency headwinds and destocking in China. Management remains optimistic with 2025 guidance expecting 2%-4% organic sales growth, supported by cost-cutting, marketing, and AI collaboration with Microsoft. |
seekingalpha.com |
2025-05-11 12:00:00 |
Czytaj oryginał (ang.) |
| Kenvue, Inc. (KVUE) Q1 2025 Earnings Call Transcript |
Kenvue, Inc. (NYSE:KVUE ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Sofya Tsinis - Head of Investor Relations Thibaut Mongon - Chief Executive Officer and Director Paul Ruh - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Peter Grom - UBS Andrea Teixeira - J.P. Morgan Anna Lizzul - Bank of America Keith Davis - Jefferies Nik Modi - RBC Capital Markets Filippo Falorni - Citi Javier Escalante - Evercore ISI Alec Legg - Canaccord Genuity Steve Powers - Deutsche Bank Korinne Wolfmeyer - Piper Sandler Operator Hello, and welcome to the Kenvue First Quarter 2025 Earnings Conference Call. |
seekingalpha.com |
2025-05-08 16:43:10 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Kenvue (KVUE) Q1 Earnings: A Look at Key Metrics |
While the top- and bottom-line numbers for Kenvue (KVUE) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-05-08 14:36:01 |
Czytaj oryginał (ang.) |
| Kenvue Boosts 2025 Sales Growth View |
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, while warning that foreign exchange would weigh on adjusted earnings. |
wsj.com |
2025-05-08 13:21:00 |
Czytaj oryginał (ang.) |
| Kenvue (KVUE) Beats Q1 Earnings and Revenue Estimates |
Kenvue (KVUE) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.28 per share a year ago. |
zacks.com |
2025-05-08 13:05:44 |
Czytaj oryginał (ang.) |
| Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Sales Outlook |
Shares of Kenvue (KVUE) rose in premarket trading Thursday after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates. |
investopedia.com |
2025-05-08 12:51:17 |
Czytaj oryginał (ang.) |
| Kenvue stock climbs as second quarter comes in ahead of forecasts |
Consumer brands firm Kenvue Inc (NYSE:KVUE) traded on the front foot in Thursday's early deals, as its second quarter beat expectations (but, fell short in year-over-year comparatives). Net sales totalled $3.74 billion in Kenvue's first quarter, exceeding the consensus forecast of $3.68 billion whilst 3.9% lower than last year's digit. |
proactiveinvestors.co.uk |
2025-05-08 11:48:02 |
Czytaj oryginał (ang.) |
| Kenvue first-quarter results beat estimates on strength in self care unit |
Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday, as strong demand for its self-care products including cough and cold medicines Tylenol and Benadryl helped offset a fall in demand for its skin health and beauty products. |
reuters.com |
2025-05-08 11:06:04 |
Czytaj oryginał (ang.) |
| Kenvue Announces Chief Financial Officer Transition |
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), today announced the appointment of Amit Banati as the Company's Chief Financial Officer, effective May 12, 2025. He will be responsible for overseeing the Finance and Strategy functions, supporting initiatives aimed at accelerating profitable growth and delivering value to shareholders. Following a thorough and thoughtful search process, Mr. Banati will succeed Paul Ruh, who will remain with the Company for a brief period to help ensure a. |
businesswire.com |
2025-05-08 10:45:00 |
Czytaj oryginał (ang.) |
| Buy 3 "Safer" Dividend Kings Of 25 From May's 55 |
The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kings, including Altria and Canadian Utilities, are now fairly priced, with annual dividends from $1K investments exceeding their single-share prices. Analysts predict net gains of 14.7% to 56.86% for the top ten Dividend Kings by yield for the coming year, based on target prices. Among the 55 Dividend Kings, 16 show negative free cash flow margins, making them cash-poor and unsafe for investment. |
seekingalpha.com |
2025-05-06 16:58:48 |
Czytaj oryginał (ang.) |
| Ahead of Kenvue (KVUE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics |
Beyond analysts' top -and-bottom-line estimates for Kenvue (KVUE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025. |
zacks.com |
2025-05-05 14:21:04 |
Czytaj oryginał (ang.) |
| 3 Dividend Stocks You Can Be Comfortable Buying and Holding, Even in a Recession |
The broader stock market indexes have recovered nicely in recent weeks. However, some investors may still fear that the impact of tariffs could lead the economy into a recession, which could have longer-lasting effects on earnings and stock prices. |
fool.com |
2025-05-04 09:30:00 |
Czytaj oryginał (ang.) |
| 2 Stocks Down 89% and 15% to Buy Right Now |
A third of the year is now over, and the stock market has seen incredible levels of volatility across the stretch. The S&P 500 index is down roughly 9.5% from its high as of this writing, and the Nasdaq Composite index has fallen 13.5%. |
fool.com |
2025-05-02 09:13:00 |
Czytaj oryginał (ang.) |
| Kenvue (KVUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release |
Kenvue (KVUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-05-01 15:07:11 |
Czytaj oryginał (ang.) |
| Loeb's Third Point builds stake in Band-Aid maker Kenvue |
Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter said on Friday, as some investors are pushing for strategic changes at the consumer healthcare company. |
reuters.com |
2025-04-25 22:16:34 |
Czytaj oryginał (ang.) |
| 5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs |
The driving force behind the recent volatility in the stock and bond markets can be boiled down to one specific item: the threat of tariffs and a global trade war. |
247wallst.com |
2025-04-25 10:41:21 |
Czytaj oryginał (ang.) |
| Kenvue to Announce First Quarter 2025 Results on May 8, 2025 |
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after. |
businesswire.com |
2025-04-24 10:45:00 |
Czytaj oryginał (ang.) |
| Two Stocks To Consider During Market Unrest To Provide Income Stability |
Investors should remain calm amid market volatility and consider buying during price dips, with 2025 expected to see more turbulence. Kenvue's strong brand portfolio and solid liquidity offer price stability and a 3.59% dividend yield, despite potential headwinds from tariffs and economic slowdown. Altria Group, with its 7% yield and Dividend King status, provides stability and potential upside during economic uncertainty, leveraging its pricing power and recession-proof products. |
seekingalpha.com |
2025-04-22 11:30:00 |
Czytaj oryginał (ang.) |
| Buy 3 "Safer" Dividend Kings Of 24 Out Of 52 For February |
Seven of the top-ten Dividend Kings by yield offer annual dividends from a $1K investment exceeding their single share prices, making them attractive buys. Six Dividend Kings, including Altria Group and Hormel Foods, are currently fair-priced, with dividends meeting or exceeding their single-share prices. Analysts predict net gains between 15% and 45.53% for the top-ten Dividend Kings by February 2026, based on target prices. |
seekingalpha.com |
2025-02-27 12:08:06 |
Czytaj oryginał (ang.) |
| Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income |
Kenvue (KVUE 0.54%) stock is down since completing its spin-off from Johnson & Johnson (JNJ 1.13%) in August 2023. But with more than a year of results now in the books, investors have had time to acclimate to Kenvue as an independent entity. |
fool.com |
2025-02-21 05:25:00 |
Czytaj oryginał (ang.) |
| Looming Challenges, But Kenvue Could Become A Compelling Dividend Growth Stock Beyond 2025 |
Kenvue, spun off from Johnson & Johnson, shows potential as a solid dividend stock post-2025 despite current economic challenges and recent earnings misses. The company boasts strong brands like Tylenol and Listerine, and management's cost-cutting initiatives aim to save $350 million by 2026. Kenvue's valuation and growth prospects make it attractive for long-term dividend investors, but cash flow headwinds warrant a hold rating for now. |
seekingalpha.com |
2025-02-17 16:00:00 |
Czytaj oryginał (ang.) |
| Buy 2 February S&P 500 Dividend Aristocrats Out Of 38 'Safer' |
Five of the ten lowest-priced Dividend Aristocrats - Franklin Resources, Realty Income, Amcor, Hormel, and Kenvue - are recommended buys, offering dividends exceeding their single share prices. Analysts project net gains of 15.84% to 46.98% by February 2025 for the Top Ten Aristocrat Dogs, with an average gain of 21.63%. Ten Aristocrats show negative free cash flow margins, making them unsafe buys; Federal Realty, Kenvue, and PepsiCo are among them. |
seekingalpha.com |
2025-02-14 11:30:38 |
Czytaj oryginał (ang.) |
| Kenvue to Webcast Presentation at the Consumer Analyst Group of New York Conference |
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available on investors.kenvue.com and a replay will be available on the website following the event. About Kenvue Kenvue Inc. i. |
businesswire.com |
2025-02-13 08:45:00 |
Czytaj oryginał (ang.) |
| Kenvue: An Intriguing Turnaround |
Kenvue's stock has underperformed since its IPO, with disappointing guidance cuts for 2023 and 2024, and minimal growth projected for 2025. Despite recent struggles, Kenvue's strong brand portfolio, including Tylenol and Band-Aid, suggests potential for a turnaround, supported by activist investor Starboard Value. Execution issues, external factors, and potential structural changes have impacted Kenvue's performance, but improvements in marketing and management could drive future growth. |
seekingalpha.com |
2025-02-10 02:03:31 |
Czytaj oryginał (ang.) |
| Kenvue Is A Mediocre Candidate |
Kenvue, the world's largest pure-play consumer health company, has a market cap of $37.96 billion but struggles with profitability despite decent growth. Management's cost-cutting initiatives show promise, but recent financials reveal mixed results, with revenue slightly up but net income and EBITDA declining. Kenvue's valuation appears relatively cheap compared to peers, yet its fundamentals don't justify a bullish outlook; thus, I rate it a 'hold'. |
seekingalpha.com |
2025-02-08 09:44:29 |
Czytaj oryginał (ang.) |
| Kenvue, Inc. (KVUE) Q4 2024 Earnings Call Transcript |
Kenvue, Inc. (NYSE:KVUE ) Q4 2024 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Thibaut Mongon - CEO Paul Ruh - CFO Sofya Tsinis - Head, IR Conference Call Participants Filippo Falorni - Citi Peter Grom - UBS Anna Lizzul - Bank of America Andrea Teixeira - J.P. Morgan Bonnie Herzog - Goldman Sachs Korinne Wolfmeyer - Piper Sandler Nik Modi - RBC Capital Markets Lauren Lieberman - Barclays Steve Powers - Deutsche Bank Operator Hello, and welcome to the Kenvue Fourth Quarter and Full-Year 2024 Earnings Conference Call. |
seekingalpha.com |
2025-02-06 16:41:17 |
Czytaj oryginał (ang.) |
| Kenvue (KVUE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates |
The headline numbers for Kenvue (KVUE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-02-06 12:36:22 |
Czytaj oryginał (ang.) |
| Kenvue's Q4 Sales Miss, Margins Improve |
Consumer healthcare products specialist Kenvue (KVUE -0.34%) reported mixed fourth-quarter and full-year earnings on Thursday, Feb. 6. Adjusted earnings per share (EPS) of $0.26 aligned with the market's consensus expectations. |
fool.com |
2025-02-06 11:24:47 |
Czytaj oryginał (ang.) |
| Kenvue (KVUE) Q4 Earnings Meet Estimates |
Kenvue (KVUE) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.31 per share a year ago. |
zacks.com |
2025-02-06 10:56:18 |
Czytaj oryginał (ang.) |
| Kenvue sees 2025 profit below estimates as strong dollar, weak cough product sales hit |
Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger dollar and weak demand for its cough and cold products that include Tylenol and Benadryl. |
reuters.com |
2025-02-06 08:49:14 |
Czytaj oryginał (ang.) |
| Kenvue Reports Full Year and Fourth Quarter 2024 Results |
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, 2024. “We delivered on our 2024 profit commitments despite headwinds that resulted in softer than expected sales growth and we enter 2025 as a more competitive company with stronger foundations,” said Thibaut Mongon, Chief Executive Officer. “We remain focused on leveraging our increased brand investments to accelerate growth and deliver lon. |
businesswire.com |
2025-02-06 08:45:00 |
Czytaj oryginał (ang.) |
| Kenvue Highlights Commitment to Shareholder Value |
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue confirms receipt of Starboard Value submission of nominees to stand for election to the Kenvue Board of Directors from. |
businesswire.com |
2025-02-05 12:39:00 |
Czytaj oryginał (ang.) |
| Neutrogena® Introduces Tate McRae as Global Brand Ambassador |
On the Heels of its 10th Anniversary, the Brand's Iconic Hydro Boost Collection Is Revealing a Juicy, Fresh Take SKILLMAN, N.J. , Feb. 4, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) announces global sensation Tate McRae as the newest face of Neutrogena®. |
prnewswire.com |
2025-02-04 18:05:00 |
Czytaj oryginał (ang.) |
| All It Takes Is $3,000 Invested in Each of These 3 Ultra-Reliable Dividend King Stocks to Help Generate Over $300 in Passive Income in 2025 |
Dividends can be a great way to generate income from stocks, no matter what the market is doing. But only if the companies paying the dividends are reliable. |
fool.com |
2025-02-04 08:45:00 |
Czytaj oryginał (ang.) |
| Gear Up for Kenvue (KVUE) Q4 Earnings: Wall Street Estimates for Key Metrics |
Get a deeper insight into the potential performance of Kenvue (KVUE) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. |
zacks.com |
2025-02-03 12:21:12 |
Czytaj oryginał (ang.) |
| Kenvue (KVUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release |
Kenvue (KVUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-01-30 13:07:31 |
Czytaj oryginał (ang.) |
| 4 Consumer Staple Stocks Likely to Top Earnings Estimates This Season |
Companies with solid brands and efficient cost-management efforts are poised to shine amid a dynamic consumer landscape. KMB, CHD, CLX and KVUE are in focus. |
zacks.com |
2025-01-27 12:45:46 |
Czytaj oryginał (ang.) |
| Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 |
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a repla. |
businesswire.com |
2025-01-23 08:45:00 |
Czytaj oryginał (ang.) |
| Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips |
As the calendar turns over to 2025, the leading Wall Street firms are releasing their top stock picks for the new year. |
247wallst.com |
2025-01-03 18:05:31 |
Czytaj oryginał (ang.) |
| 3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025 |
Investors worried about a stock market sell-off may feel the urge to sell out of their positions and run for the exits. But long-term investors know that it's a mistake to overhaul your investing strategy based on emotion. |
fool.com |
2024-12-29 11:07:00 |
Czytaj oryginał (ang.) |
| A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now |
Even with the recent bout of market volatility, 2024 has been a fantastic year for stocks. The S&P 500 index has delivered a dividend-adjusted total return of roughly 25% across this year's trading. |
fool.com |
2024-12-23 07:25:00 |
Czytaj oryginał (ang.) |
| Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends |
"A Dividend King [is] a stock with 50 or more consecutive years of dividend increases." - suredividend.com. 53 Divided Kings, screened as of December 11, 2024, represented all eleven Morningstar Sectors. Broker-estimated top-ten net gains ranged from 14.79% to 25.23%, topped by SJW and SWK. By yield, MO topped all the Kings. Top-ten yields from ABBV, ADM, SWK, FRT, FTS, BKH, NWN, CDUAF, UVV, and MO averaged 4.67%. |
seekingalpha.com |
2024-12-13 06:41:09 |
Czytaj oryginał (ang.) |
| Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends |
"Dividend Aristocrats |
seekingalpha.com |
2024-12-10 17:42:55 |
Czytaj oryginał (ang.) |
| Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months. |
Investors often gravitate toward super safe dividend stocks to collect passive income and limit market volatility. But sometimes, even stodgy, boring companies can crush the market. |
fool.com |
2024-12-04 11:53:00 |
Czytaj oryginał (ang.) |
| Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade) |
Kenvue's recent earnings showed improvements, but persistent headwinds, especially in the Skin, Health, & Beauty segment, suggest limited upside potential in the near term. Despite solid dividend growth and cost-cutting initiatives, higher interest rates and economic challenges in China continue to weigh on Kenvue's performance. Management's strategic moves, including increased online presence and partnerships with influencers, aim to combat headwinds and drive future growth. |
seekingalpha.com |
2024-11-27 09:13:00 |
Czytaj oryginał (ang.) |
| Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference |
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company's participation in the Morgan Stanley Global Consumer & Retail Conference in New York City. Thibaut Mongon, Chief Executive Officer and Paul Ruh, Chief Financial Officer will participate in a fireside chat on Wednesday, December 4, 2024, at 11:45 a.m. Eastern Time. A live webcast of the fireside chat will be available on investors.kenvue.com and a replay will be available on the website followin. |
businesswire.com |
2024-11-25 08:00:00 |
Czytaj oryginał (ang.) |
| Tylenol maker Kenvue hails efficiency gains as activist Starboard watches on |
Kenvue Inc (NYSE:KVUE), the maker of Listerine, Tylenol, Aveeno and Band-Aid, reported slightly lower sales than expected but earnings were just above Wall Street estimates. The company has been in a more intense spotlight coming into these results after reports emerged that activist investor Starboard Value has taken a stake and is eyeing changes. |
proactiveinvestors.com |
2024-11-07 14:41:18 |
Czytaj oryginał (ang.) |
| Kenvue, Inc. (KVUE) Q3 2024 Earnings Call Transcript |
Kenvue, Inc. (NYSE:KVUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Sofya Tsinis - Head, IR Thibaut Mongon - CEO Paul Ruh - CFO Conference Call Participants Bonnie Herzog - Goldman Sachs Anna Lizzul - Bank of America Andrea Teixeira - J.P. Morgan Peter Grom - UBS Filippo Falorni - Citi Steve Powers - Deutsche Bank Keith Devas - Jefferies Nik Modi - RBC Capital Markets Korinne Wolfmeyer - Piper Sandler Jeremy Fialko - HSBC Operator Hello, and welcome to the Kenvue Third Quarter 2024 Earnings Conference Call. |
seekingalpha.com |
2024-11-07 13:09:13 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About Kenvue (KVUE) Q3 Earnings |
Although the revenue and EPS for Kenvue (KVUE) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-07 12:35:55 |
Czytaj oryginał (ang.) |
| Kenvue (KVUE) Q3 Earnings Surpass Estimates |
Kenvue (KVUE) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.31 per share a year ago. |
zacks.com |
2024-11-07 10:56:12 |
Czytaj oryginał (ang.) |
| Kenvue misses quarterly sales estimates on sluggish skincare sales |
Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its skin health and beauty unit housing the Neutrogena and Aveeno brands, amid pressure from activist hedge fund Starboard Value. |
reuters.com |
2024-11-07 08:51:19 |
Czytaj oryginał (ang.) |
| Kenvue Reports Third Quarter 2024 Results |
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”), today announced financial results for the fiscal third quarter ended September 29, 2024. |
businesswire.com |
2024-11-07 08:45:00 |
Czytaj oryginał (ang.) |
| Stay Ahead of the Game With Kenvue (KVUE) Q3 Earnings: Wall Street's Insights on Key Metrics |
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Kenvue (KVUE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024. |
zacks.com |
2024-11-04 12:21:24 |
Czytaj oryginał (ang.) |
| This Big New Development Could Be Bullish for Kenvue Stock |
Can tinkering around the edges actually make this stock more attractive? |
fool.com |
2024-10-30 08:15:00 |
Czytaj oryginał (ang.) |
| 3 Dividend Stocks to Double Up on Right Now |
While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio. |
fool.com |
2024-10-27 14:16:00 |
Czytaj oryginał (ang.) |
| Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy. |
Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock. |
fool.com |
2024-10-26 22:42:00 |
Czytaj oryginał (ang.) |
| Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months |
An activist investor is taking a stake in Kenvue stock. |
fool.com |
2024-10-26 22:12:00 |
Czytaj oryginał (ang.) |
| How activist Starboard may help boost value in Kenvue's skin and beauty business |
Starboard Value and Kenvue seem to be aligned, and the conditions might be right for value creation. |
cnbc.com |
2024-10-26 12:24:25 |
Czytaj oryginał (ang.) |